 |
EU822-03 - Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine as Induction Therapy for Early Stage Breast Cancer
| | | Principal Investigator: Ruth M. O’Regan, MD |
ABX 018 - NeoAdjuvant Trial of Trastuzumab in Combination with Dose-Dense ABI007 (Abraxane) followed by Vinorelbine for HER2 Overexpressing Early Stage Breast Cancer
| | | Principal Investigator: Ruth M. O’Regan, MD
Medical Director: Amelia B. Zelnak, MD |
Pfizer A7471028 - Randomized Phase 2 Trial of PF-00299804 Versus Erlotinib For The Treatment Of Advanced Non-Small Cell Lung Cancer After Failure of At Least One Prior Chemotherapy Regimen
| | | Principal Investigator: Suresh S. Ramalingam, MD |
University of Arizaona Center for Integrative Medicine - A Pilot Trial to Assess the Effect of a Web-Based Continuing Education on Integrative Medicine Approaches to Prostate Cancer
| | |
Co-Principal Investigator: Matthew P. Mumber, MD |
Sites by Study
|
EU822-03 |
ABX 018 |
Pfizer A7471028 |
U of AZ
CIM |
| Augusta Oncology Associates |
• |
|
|
|
| Central Georgia Cancer Care |
• |
|
|
• |
| DeKalb Medical |
• |
• |
• |
|
| Georgia Cancer Center for Excellence at Grady |
• |
• |
• |
|
| Georgia Cancer Specialists |
• |
• |
• |
• |
| Harbin Clinic |
|
|
|
• |
| John. B. Amos Cancer Center |
• |
|
• |
|
| Lewis Cancer Research Pavilion at St. Joseph's/Candler |
|
|
|
• |
| Memorial Health University Medical Center |
|
|
|
• |
| Northeast Georgia Cancer Care |
|
• |
• |
• |
| Northwest Georgia Oncology Centers |
• |
• |
|
• |
| Peachtree Hematology Oncology Consultants |
|
• |
|
• |
| Piedmont Hospital |
|
• |
|
• |
| Saint Joseph's Hospital of Atlanta |
|
|
|
• |
| Wellstar Health System |
• |
|
|
|
| Winship Cancer Institute of Emory University |
• |
• |
• |
• |
|
|